BDNF and Parkinson disease: Finally, another promising approach has been the development of a small-size orally active molecule (PYM50028) able to increase levels of GDNF and BDNF in the striatum of MPTP-lesioned mice, considered as a good candidate for neuroprotection and neurorepair in PD [194].